Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors.

Huang, J; Mo, HN; Wu, DW; Chen, XL; Ma, LY; Lan, B; Qu, D; Yang, Q; Xu, BH

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):